Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30599590 | 1.00 | NPC1 (0.35) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL10778908 | 0.87 | NPC1 (0.36) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL29444201 | 0.82 | APEX1 (0.35) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL6742007 | 0.82 | NPC1 (0.39) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL6742012 | 0.81 | APEX1 (0.33) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL2187400 | 0.78 | CA1 (0.37) | ALDH1A1APEX1 | |
| SCHEMBL29520649 | 0.77 | ALDH1A1 (0.36) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL5888063 | 0.77 | ALDH1A1 (0.36) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL5073993 | 0.76 | APEX1 (0.36) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL9298609 | 0.73 | APEX1 (0.39) | APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022204-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF | ADEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4582507-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF | ADEKA CORPORATION (JP) | 2025-07-09 | — | — | EP | disclosed |
| WO-2023196799-A2 | PHOSPHITE-CONTAINING SORBENTS, SYSTEMS INCLUDING PHOSPHITE-CONTAINING SORBENTS, AND METHODS USING THE PHOSPHITE-CONTAINING SORBENTS | GLOBAL THERMOSTAT OPERATIONS, LLC. (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023163145-A1 | OPTICAL LAMINATE FOR OLED DISPLAY DEVICE | 日東電工株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023163143-A1 | ADHESIVE FILM FOR OLED DISPLAY DEVICE | 日東電工株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023163141-A1 | OPTICAL LAMINATE FOR OLED DISPLAY DEVICE | 日東電工株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023163152-A1 | OPTICAL LAMINATE FOR OLED DISPLAY DEVICE | 日東電工株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023163147-A1 | OPTICAL LAMINATE FOR OLED DISPLAY DEVICE | 日東電工株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023163148-A1 | OPTICAL LAMINATE FOR OLED DISPLAY DEVICE | 日東電工株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023163146-A1 | ADHESIVE FILM FOR OLED DISPLAY DEVICE | 日東電工株式会社 | 2023-08-31 | — | — | WO | disclosed |
| US-20040176510-A1 | Flameproofed thermoplastic molding compounds | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-09 | — | — | US | disclosed |
| EP-0634445-B1 | Light diffuser composition | DOW CHEMICAL CO (US) | 1999-08-11 | — | — | EP | disclosed |
| EP-0622404-B1 | Crystalline synthetic resin composition containing a group III or IV metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KK (JP) | 1998-07-08 | — | — | EP | disclosed |
| EP-0658556-B1 | Piperidine compound and stabilized polymeric material composition containing the same | ASAHI DENKA KOGYO KK (JP) | 1997-05-28 | — | — | EP | disclosed |
| US-5455347-A | Di(2,2,6,6-tetramethylpiperidyl)-diaminotriazine derivatives as polymeric stabilizers giving heat, light and weather resistance | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1995-10-03 | — | — | US | disclosed |
| EP-0658556-A1 | Piperidine compound and stabilized polymeric material composition containing the same | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1995-06-21 | — | — | EP | disclosed |
| EP-0634445-A1 | Light diffuser composition | THE DOW CHEMICAL COMPANY (US) | 1995-01-18 | — | — | EP | disclosed |
| US-5362783-A | Polycarbonate blend, a phosphine and a hindered phenol, discoloration inhibition | THE DOW CHEMICAL COMPANY (US) | 1994-11-08 | — | — | US | disclosed |
| US-5342868-A | Containing alkali metal salt and polyvalent metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1994-08-30 | — | — | US | disclosed |
| US-4957953-A | MONO-AND POLYTETRAMETHYLPIPERIDINE ESTERS | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022204-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF | PHOSPHO1, EBP, CA1 | NPC1 3112/4885ALDH1A1 966/4885PLA2G1B 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.